CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Certified by Founder
Lodge
Accern
start up
United States
- New York
- 02/05/2022
- Series B
- $20,000,000
No Code. No Complexity. NLP.
- Industry Software Development
- Website https://accern.com/
- LinkedIn https://www.linkedin.com/company/accern/
Related People
Kumesh AroomooganCo Founder
United States -
New York, New York
I am the co-founder and CEO (Forbes 30 under 30) of Accern, an NYC-based venture-backed AI startup whose mission is to accelerate AI for enterprise with a no-code development platform.
LinkedIn
https://www.linkedin.com/in/kumesh/
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)